Find Faculty

Robert Sebra, PhD

img_Robert Sebra
PROFESSOR | Genetics and Genomic Sciences
332-243-0721
email
Research Topics
Biomedical Informatics, Cancer, Cancer Genetics, Epigenetics, Gene Expressions, Genetics, Infectious Disease, Molecular Biology, RNA, RNA Splicing & Processing, Stem Cells, Technology & Innovation, Translational Research
Multi-Disciplinary Training Area
Cancer Biology [CAB], Genetics and Genomic Sciences [GGS]
247
Publications

Selected Publications

Author Correction: A streamlined base editor engineering strategy to reduce bystander editing (Nature Communications, (2025), 16, 1, (8115), 10.1038/s41467-025-63609-6). Izabella Valdez, Ian O’Connor, Divesh Patel, Katherine Gierer, Jan Harrington, Ethan Ellis, Stephen A. Caponetti, Robert P. Sebra, Hillary C. Valley, Kevin Coote, Martin Mense, Samuele G. Marro, Tingting Jiang. Nature Communications

Mutational patterns in a large cohort of parathyroid carcinomas. Chetanya Pandya, Andrew V. Uzilov, Jessica Costa-Guda, Justin Bellizzi, Patricia Taik, Aye S. Moe, Maya Strahl, Karin van der Tuin, Mark Stevenson, Branca M. Cavaco, Filomena Cetani, Claudio Marcocci, Auli Karhu, Johanna Arola, Camilla Schalin-Jäntti, Hans Morreau, Rajesh V. Thakker, Eric E. Schadt, Robert Sebra, Shuyu D. Li, Rong Chen, Andrew Arnold. Journal of Endocrinological Investigation

Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease. Donghoon Lee, James M. Vicari, Christian Porras, Collin Spencer, Milos Pjanic, Xinyi Wang, Seon Kinrot, Philipp Weiler, Roman Kosoy, Jaroslav Bendl, Prashant N M, Konstantina Psychogyiou, Periklis Malakates, Evelyn Hennigan, Jennifer Monteiro Fortes, Shiwei Zheng, Karen Therrien, Deepika Mathur, Steven P. Kleopoulos, Zhiping Shao, Stathis Argyriou, Marcela Alvia, Clara Casey, Aram Hong, Kristin G. Beaumont, Robert Sebra, Christopher P. Kellner, David A. Bennett, Guo Cheng Yuan, Georgios Voloudakis, Fabian J. Theis, Vahram Haroutunian, Gabriel E. Hoffman, John F. Fullard, Panos Roussos. Nature Genetics

View All Publications

Icahn (East) Building Floor 14 Room 14-20E

1425 Madison Ave

New York, NY 10029

332-243-0721

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Sebra during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Panacent Bio

Founder/Co-Founder/Partner

  • Panacent Bio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.